LANTERN PHARMA INC's ticker is LTRN and the CUSIP is 51654W101. A total of 27 filers reported holding LANTERN PHARMA INC in Q3 2022. The put-call ratio across all filers is 4.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $579,828 | -40.0% | 170,031 | -0.8% | 0.01% | -45.5% |
| Q2 2023 | $967,058 | +16.3% | 171,465 | -0.4% | 0.01% | +10.0% |
| Q1 2023 | $831,344 | +79530.7% | 172,115 | -0.4% | 0.01% | – |
| Q4 2022 | $1,044 | -99.9% | 172,838 | +1.1% | 0.00% | -100.0% |
| Q3 2022 | $817,000 | -15.9% | 171,019 | +0.6% | 0.01% | -18.8% |
| Q2 2022 | $971,000 | -20.0% | 169,972 | +0.1% | 0.02% | -20.0% |
| Q1 2022 | $1,214,000 | -9.0% | 169,771 | +1.6% | 0.02% | 0.0% |
| Q4 2021 | $1,334,000 | -23.5% | 167,106 | +7.2% | 0.02% | -53.5% |
| Q3 2021 | $1,743,000 | -21.1% | 155,859 | +3.0% | 0.04% | -27.1% |
| Q2 2021 | $2,209,000 | – | 151,316 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SANDERS MORRIS HARRIS LLC | 365,930 | $1,721,000 | 0.42% |
| CM Management, LLC | 50,000 | $239,000 | 0.27% |
| WOLFF WIESE MAGANA LLC | 30,462 | $146,000 | 0.12% |
| Redmond Asset Management, LLC | 49,502 | $237,000 | 0.09% |
| CARLSON CAPITAL L P | 168,000 | $803,000 | 0.06% |
| NewEdge Advisors, LLC | 171,019 | $817,000 | 0.01% |
| Sigma Planning Corp | 17,500 | $84,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 3,984 | $19,000 | 0.00% |
| NORTHERN TRUST CORP | 12,629 | $60,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |